Free Trial

Design Therapeutics (DSGN) Insider Trading & Ownership

→ The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad)
Free DSGN Stock Alerts
$3.76
+0.11 (+3.01%)
(As of 04/25/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Design Therapeutics (NASDAQ:DSGN) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
27.80%
Number Of
Insiders Buying
(Last 12 Months)
3
Amount Of
Insider Buying
(Last 12 Months)
$176,820.38
Number Of
Insiders Selling
(Last 12 Months)
0
Get DSGN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Design Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

DSGN Insider Buying and Selling by Quarter

Ad Wall Street Star
AI finds its first serious application
AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.
Click here to learn more about the booming eHealth industry

Design Therapeutics Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/25/2024John P SchmidDirectorBuy17,809$3.74$66,605.66  
3/22/2024John P SchmidDirectorBuy9,156$3.62$33,144.72  
9/29/2023Rodney W LappeDirectorBuy21,000$2.35$49,350.00  
8/29/2023Deepa PrasadDirectorBuy12,000$2.31$27,720.00  
(Data available from 1/1/2013 forward)

DSGN Insider Trading Activity - Frequently Asked Questions

Who is on Design Therapeutics's Insider Roster?

The list of insiders at Design Therapeutics includes Arsani William, Deepa Prasad, Joao Md Siffert, John P Schmid, Rodney W Lappe, Simeon George, Sr One Capital Fund I Aggregat, and Stella Xu. Learn more on insiders at DSGN.

What percentage of Design Therapeutics stock is owned by insiders?

27.80% of Design Therapeutics stock is owned by insiders. Learn more on DSGN's insider holdings.

Which Design Therapeutics insiders have been buying company stock?

The following insiders have purchased DSGN shares in the last 24 months: Deepa Prasad ($27,720.00), Joao Md Siffert ($9,740.50), John P Schmid ($99,750.38), Rodney W Lappe ($168,750.00), Simeon George ($7,246,800.00), and Sr One Capital Fund I Aggregat ($325,600.00).

How much insider buying is happening at Design Therapeutics?

Insiders have purchased a total of 976,115 DSGN shares in the last 24 months for a total of $7,878,360.88 bought.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:DSGN) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
These AI trades triggered this morning (545% return)
Prosper Trading Academy
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
He Is Giving Away Bitcoin
Crypto Swap Profits
Jim Cramer’s “The Biggest Drug Ever”
Behind the Markets
Your Money is Not Safe
American Alternative
The AI stock to buy right now
StockEarnings